fda warning letters compounding semaglutide october 2025 issued 25 to telehealth companies for false and misleading claims about compounded GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of Congress Introduces SAFE Drugs Act

Additionally, increasing healthcare infrastructure, rising awareness about metabolic diseases, and supportive government policies are boosting market growth

switched to placebo after reaching goal weight STEP 4 SURMOUNT-4 Continued therapy additional weight loss Switched to placebo weight regain Both arms completed an open-label loss phase before randomization

The first one or two shots will not give you that immediate improvement you might expect

Article published: 6/11/26 GLP-1 and the New Consumer Economy Somewhere between the hot sauce and the expired salad dressing sits a weekly injection responsible for rewriting the consumer economy